Evaluation of Comfort in Symptomatic Contact Lens Wearers
1 other identifier
interventional
17
1 country
1
Brief Summary
The purpose of this study is to evaluate the comfort of an ocular lubricant in symptomatic contact lens wearers. This study will be conducted in Canada.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 6, 2021
CompletedFirst Posted
Study publicly available on registry
July 15, 2021
CompletedStudy Start
First participant enrolled
July 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 29, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 29, 2021
CompletedNovember 3, 2021
November 1, 2021
3 months
July 6, 2021
November 2, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comfort, collected for each eye
A visual analogue scale will be used
Up to Day 6
Study Arms (1)
FID123238
EXPERIMENTALFID123238 applied to the ocular surface, 1 application per day, for five consecutive days
Interventions
Eligibility Criteria
You may qualify if:
- Is able to understand and sign an approved information consent letter;
- Habitually wears daily disposable soft contact lenses in both eyes;
- Is able to achieve 20/40 or better monocular VA with habitual contact lenses;
- Has a pair of spectacles for vision correction.
You may not qualify if:
- Routinely sleeps in habitual contact lenses;
- Has any known active ocular disease and/or infection;
- Is pregnant or lactating;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Alcon Researchlead
Study Sites (1)
Alcon Investigative Site 6189
Waterloo, Ontario, N2L 3G1, Canada
Study Officials
- STUDY DIRECTOR
Clinical Trial Lead, Dry Eye
Alcon Research, LLC
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2021
First Posted
July 15, 2021
Study Start
July 22, 2021
Primary Completion
October 29, 2021
Study Completion
October 29, 2021
Last Updated
November 3, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share